STING1 and cancer: Taken together, our results strongly suggest that STING activation—intrinsic to 4T1M responsive cancer cells—accounts for the induction of Ly6Ehi neutrophils, as mediated by IFN, and in-turn the ability of these cells to predict but also induce immunotherapy response.